Abiopharma

🔍 SIMMONS DAVID S (Executive)

Company: Viatris Inc (VTRS)

Report Date: 2025-08-27

Detailed Transactions and Holdings:

• Acquired 286 shares of Common Stock at $10.423 per share (Direct)
  Date: 2025-08-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 970.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 213 shares of Common Stock at $10.4255 per share (Direct)
  Date: 2025-11-03 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,183.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Acquired 22,820 shares of Common Stock (Direct)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 22,820.00 | transaction_form_type: 4
• Acquired 524 shares of Common Stock (Direct)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 23,344.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 22,820 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5, F5
• Sold 523 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6, F6
• Acquired 15,890 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 15,890.00 | transaction_form_type: 4 | Footnotes: F7, F7

Footnotes:

• F1: These shares were acquired by the reporting person's investment advisors in managed accounts as part of the investment advisors' implementation and continued execution of managed investment strategies to mirror certain index funds involving the securities of multiple issuers.
• F2: Based on information provided by the investment advisor; additional information, including the price range, if any, is unavailable.
• F3: These shares are held in family trusts for which the reporting person or his spouse serve as trustee: (i) 13 shares in a trust for the benefit of the reporting person for which the reporting person serves as trustee; (ii) 63 shares in a trust for the benefit of the reporting person and his children for which the reporting person serves as trustee; (iii) 522 shares in a trust for the benefit of the reporting person's spouse for which the reporting person's spouse serves as trustee; and (iv) 585 shares in trusts for the benefit of the reporting person's children for which the reporting person's spouse serves as trustee.
• F4: Fractional shares have been rounded up in connection with the settlement described in footnote 6 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
• F5: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.
• F6: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on August 11, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
• F7: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.